Prakiraan wutah bathi resik saben saham kanggo taun ngarep Theriva Biologics (TOVX)

Simbol lan logo merek Synthetic Biologics (TOVX)

Theriva Biologics, Inc. (TOVX) is monetizing the development of VCN-01 to combat pancreatic and ocular cancers, relying exclusively on research alliances with oncology centers. The modeled EPS growth for the next fiscal year serves as an indicator of market expectations, where the 19.60 level reflects the current magnitude of the profit forecast. Company management is aggressively developing its innovative immunotherapy platform through a series of clinical trials.

TOVX - Prakiraan wutah bathi kanggo taun ngarep Synthetic Biologics ing rentang 28.04.2023 - 18.11.2026

Rincian metrik lan analitis perusahaan Synthetic Biologics (TOVX)

- rega lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:Synthetic Biologics
Barang utama Theriva Biologics Inc

This indicator reflects the dynamics of analysts' consensus forecasts for earnings per share changes, eliminating reporting time lags through daily updates of expectations. By analyzing the projected EPS growth rate for the coming year, an investor assesses the probability of commercial success for the oncolytic platforms of Theriva Biologics, Inc. (TOVX), where any sharp fluctuations in the line signal critical changes in clinical trial results.

Pesaing langsung

Prakiraan wutah bathi resik saben saham kanggo taun ngarep immunitybio.com|Prakiraan wutah bathi saben saham kanggo taun ngarep immunocore.com (IMCR)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Janux Therapeutics Inc (JANX)|Prakiraan wutah bathi saben saham kanggo taun ngarep Arcus Bio RCUS|Zymeworks Inc - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Tango Therapeutics Corp TNGX|IOVA - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMTX (immatics.com) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Xencor Inc. (XNCR) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Compass Bio (CMPX)|Prakiraan wutah bathi saben saham kanggo taun ngarep REPL|LYEL - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep IPHA (Innate Pharma, S.A.)|Proyeksi tambahing bathi saben saham ing taun ngarep PYXS|Prakiraan wutah bathi kanggo taun ngarep CGEN (Compugen Ltd.)|Dinamika bathi saben saham sing diarepake ing taun ngarep IOBT|sutrobio.com - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep MiNK Therapeutics, Inc|Werewolf (HOWL) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Immix Biopharma Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|ALXO (alxoncology.com) - Prakiraan wutah bathi kanggo taun ngarep|Cue Biopharma, Inc. - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep pdsbiotech.com (PDSB)|SONN: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|MAIA Biotech - Prakiraan wutah bathi saben saham kanggo taun ngarep|liminatuspharma.com (LIMN) - Prakiraan wutah bathi resik saben saham ing taun ngarep|LVTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NXTC (NextCure) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|LPTX: Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep INTS|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Sensei Biotherapeutics, Inc.|Gritstone bio (GRTS) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep KA|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep NexImmune Inc|Prakiraan wutah bathi resik saben saham kanggo taun ngarep turnstonebio.com TSBX|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Vaccinex Inc (VCNX)|HARP - Prakiraan wutah bathi resik saben saham kanggo taun ngarep